AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan

Start Date : February 26, 2019
End Date : February 28, 2019
Time : 9:00 am to5:00 pm

Email :

Location :
Hilton Tokyo Bay, 1-8 Maihama, Urayasu-shi, 279-0031, Japan


Get Direction View Large Map


Register your team today and join 300 scientists and executives at our upcoming meeting, held February 26 - 28, 2019 in Tokyo.

AsiaTIDES 2019 keynote presentation lineup:

1) The Discovery of Semaglutide – A Journey from Ala Scan to Structural Design of GLP-1 Analogues
- Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S

2) New Strategies and Technologies in Oligonucleotide Therapeutic Development
- Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals

3) The Chemistry behind Approved Oligonucleotide Therapeutics
- Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc.

4) From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics
- Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences


Conference Pass + Pre-Conference Workshop: USD 3023.0,
Conference Pass: USD 2375.0


Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences

Category: Conferences | Education

Organized by

Organized by LoveEvvnt1

KNect365 Life Sciences


Event Categories: Health & Nutrition.

Your Review

You must be logged in to post a comment.